Effect of Cilostazol on Treadmill Walking, Community‐Based Walking Ability, and Health‐Related Quality of Life in Patients with Intermittent Claudication Due to Peripheral Arterial Disease: Meta‐Analysis of Six Randomized Controlled Trials
Top Cited Papers
- 1 December 2002
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 50 (12) , 1939-1946
- https://doi.org/10.1046/j.1532-5415.2002.50604.x
Abstract
OBJECTIVES: To assess whether cilostazol, a phosphodiesterase III inhibitor, improves treadmill and community‐based walking ability and health‐related quality of life (HQL) in patients with intermitt...Keywords
This publication has 16 references indexed in Scilit:
- A comparison of cilostazol and pentoxifylline for treating intermittent claudicationThe American Journal of Medicine, 2000
- A New Pharmacological Treatment for Intermittent Claudication:Archives of internal medicine (1960), 1999
- Determining Clinically Important Differences in Health Status MeasuresPharmacoEconomics, 1999
- Exercise training improves functional status in patients with peripheral arterial diseaseJournal of Vascular Surgery, 1996
- The MOS 36-Item Short-Form Health Survey (SF-36)Medical Care, 1993
- Benefit of exercise conditioning for patients with peripheral arterial disease.Circulation, 1990
- The Medical Outcomes StudyJAMA, 1989
- The Medical Outcomes Study. An application of methods for monitoring the results of medical careJAMA, 1989
- The Evaluation of Exercise Performance in Patients with Peripheral Vascular DiseaseJournal of Cardiopulmonary Rehabilitation, 1988